Literature DB >> 21968748

A simplified method for the generation of human osteoclasts in vitro.

James J Cody, Angel A Rivera, Jianzhong Liu, Julian M Liu, Joanne T Douglas, Xu Feng.   

Abstract

Osteoclasts are large, multinucleated cells responsible for the resorption of mineralized bone matrix. These cells are critical players in the bone turnover involved in bone homeostasis. Osteoclast activity is connected to the establishment and expansion of skeletal metastases from a number of primary neoplasms. Thus, the formation and activation of osteoclasts is an area of research with many potential avenues for clinical translation. Past studies of osteoclast biology have utilized primary murine cells cultured in vitro. Recently, techniques have been described that involve the generation of osteoclasts from human precursor cells. However, these protocols are often time-consuming and insufficient for generating large numbers of osteoclasts. We therefore developed a simplified protocol by which human osteoclasts may be easily and reliably generated in large numbers in vitro. In this study, osteoclasts were differentiated from bone marrow cells that had been aliquotted and frozen. Cells were generated by culture with recombinant macrophage colony-stimulating factor (M-CSF) and receptor activator of NF-κB ligand (RANKL). Both human and murine RANKL were shown to efficiently generate osteoclasts, although higher concentrations of murine RANKL were required. Formation of osteoclasts was demonstrated qualitatively by tartrate-resistant acid phosphatase (TRAP) staining. These cells were fully functional, as confirmed by their ability to form resorption pits on cortical bone slices. Functional human osteoclasts can be difficult to generate in vitro by current protocols. We have demonstrated a simplified system for the generation of human osteoclasts in vitro that allows for large numbers of osteoclasts to be obtained from a single donor.

Entities:  

Year:  2011        PMID: 21968748      PMCID: PMC3180092     

Source DB:  PubMed          Journal:  Int J Biochem Mol Biol        ISSN: 2152-4114


  20 in total

1.  Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

Authors:  W S Simonet; D L Lacey; C R Dunstan; M Kelley; M S Chang; R Lüthy; H Q Nguyen; S Wooden; L Bennett; T Boone; G Shimamoto; M DeRose; R Elliott; A Colombero; H L Tan; G Trail; J Sullivan; E Davy; N Bucay; L Renshaw-Gegg; T M Hughes; D Hill; W Pattison; P Campbell; S Sander; G Van; J Tarpley; P Derby; R Lee; W J Boyle
Journal:  Cell       Date:  1997-04-18       Impact factor: 41.582

2.  Expression of estrogen receptor-alpha in cells of the osteoclastic lineage.

Authors:  R O Oreffo; V Kusec; A S Virdi; A M Flanagan; M Grano; A Zambonin-Zallone; J T Triffitt
Journal:  Histochem Cell Biol       Date:  1999-02       Impact factor: 4.304

3.  Upmodulation of multinucleated cell formation in long-term human bone marrow cultures by leukaemia inhibitory factor (LIF).

Authors:  D Heymann; F Gouin; J Guicheux; J C Munevar; A Godard; G Daculsi
Journal:  Cytokine       Date:  1997-01       Impact factor: 3.861

Review 4.  Bone resorption by osteoclasts.

Authors:  S L Teitelbaum
Journal:  Science       Date:  2000-09-01       Impact factor: 47.728

5.  Annexin II stimulates RANKL expression through MAPK.

Authors:  Fanghong Li; Hoyeon Chung; Sakamuri V Reddy; Ganwei Lu; Noriyoshi Kurihara; Allan Z Zhao; G David Roodman
Journal:  J Bone Miner Res       Date:  2005-02-14       Impact factor: 6.741

6.  A Glanzmann's mutation in beta 3 integrin specifically impairs osteoclast function.

Authors:  X Feng; D V Novack; R Faccio; D S Ory; K Aya; M I Boyer; K P McHugh; F P Ross; S L Teitelbaum
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

7.  Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL.

Authors:  H Yasuda; N Shima; N Nakagawa; K Yamaguchi; M Kinosaki; S Mochizuki; A Tomoyasu; K Yano; M Goto; A Murakami; E Tsuda; T Morinaga; K Higashio; N Udagawa; N Takahashi; T Suda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

8.  Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.

Authors:  Gerald J Atkins; Panagiota Kostakis; Katie J Welldon; Cristina Vincent; David M Findlay; Andrew C W Zannettino
Journal:  J Cell Physiol       Date:  2005-06       Impact factor: 6.384

9.  Generation of human osteoclasts in stromal cell-free and stromal cell-rich cultures: differences in osteoclast CD11c/CD18 integrin expression.

Authors:  C S Lader; J Scopes; M A Horton; A M Flanagan
Journal:  Br J Haematol       Date:  2001-02       Impact factor: 6.998

10.  Resorbability of bone substitute biomaterials by human osteoclasts.

Authors:  Arndt F Schilling; Wolfgang Linhart; Sandra Filke; Matthias Gebauer; Thorsten Schinke; Johannes M Rueger; Michael Amling
Journal:  Biomaterials       Date:  2004-08       Impact factor: 12.479

View more
  7 in total

1.  Macrophage colony-stimulating factor pretreatment of bone marrow progenitor cells regulates osteoclast differentiation based upon the stage of myeloid development.

Authors:  Xuehui Yang; Shivangi Pande; Cameron Scott; Robert Friesel
Journal:  J Cell Biochem       Date:  2019-02-25       Impact factor: 4.429

Review 2.  Modulation of Osteoclast Interactions with Orthopaedic Biomaterials.

Authors:  Chris Steffi; Zhilong Shi; Chee Hoe Kong; Wilson Wang
Journal:  J Funct Biomater       Date:  2018-02-26

Review 3.  Engineering in-vitro stem cell-based vascularized bone models for drug screening and predictive toxicology.

Authors:  Alessandro Pirosa; Riccardo Gottardi; Peter G Alexander; Rocky S Tuan
Journal:  Stem Cell Res Ther       Date:  2018-04-20       Impact factor: 6.832

4.  Establishment and validation of an in vitro co-culture model for oral cell lines using human PBMC-derived osteoclasts, osteoblasts, fibroblasts and keratinocytes.

Authors:  Daniel Steller; Alexandra Scheibert; Tabea Sturmheit; Samer G Hakim
Journal:  Sci Rep       Date:  2020-10-08       Impact factor: 4.379

5.  Netrin-1 regulates ERK1/2 signaling pathway and autophagy activation in wear particle-induced osteoclastogenesis.

Authors:  Lei Wang; Zhibiao Gao; Jie Zhang; Yulong Huo; Qiang Xu; Yusheng Qiu
Journal:  Cell Biol Int       Date:  2021-01-13       Impact factor: 3.612

6.  IgA Immune Complexes Induce Osteoclast-Mediated Bone Resorption.

Authors:  Annelot C Breedveld; Melissa M J van Gool; Myrthe A M van Delft; Conny J van der Laken; Teun J de Vries; Ineke D C Jansen; Marjolein van Egmond
Journal:  Front Immunol       Date:  2021-07-01       Impact factor: 7.561

7.  Expression of osteoprotegerin from a replicating adenovirus inhibits the progression of prostate cancer bone metastases in a murine model.

Authors:  James J Cody; Angel A Rivera; Gray R Lyons; Sherry W Yang; Minghui Wang; Jason W Ashley; Sreelatha Meleth; Xu Feng; Gene P Siegal; Joanne T Douglas
Journal:  Lab Invest       Date:  2013-01-28       Impact factor: 5.662

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.